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compensate for this unknown lignification regulator. An Oncogenic Mutations in B-Raf:
important approach to discovering such unknown fac- Some Losses Yield Gainstors will be to identify the direct targets of the de-
hiscence regulators, all of which seem to encode DNA
binding transcription factors.
The other issue that needs to be tackled is how the A study by Wan et al. in this issue of Cell demonstrates
initial pattern of this regulatory network is set up. Fortu- that the majority of oncogenic mutations in the B-Raf
nately, we know quite a bit about the early steps of protein kinase result in increased catalytic activity,
flower development, which begins with the decision of through disruption of the autoinhibited state of the
a plant to make individual flowers in response to environ- kinase domain. Surprisingly, several mutations lead to
mental and intrinsic cues. The immediate result of floral impaired B-Raf kinase activity, yet these mutants are
induction is the transcriptional activation of a small set nevertheless capable of stimulating downstream sig-
of integrator genes. These in turn positively regulate naling through transactivation of C-Raf.
homeotic genes that control the identity of floral organs
including the central carpels, which produce the fruit. The Raf-MEK-ERK protein kinase cascade is a highly
Surprisingly, FUL activation occurs independently of conserved signaling pathway in eukaryotes, which links,
carpel formation, while SHP expression does not. Simi- for example, growth factor stimulation to cell prolifera-
larly mystifying is the observation that several genes tion. Raf is a protein serine/threonine kinase for which
affecting other aspects of fruit patterning are also ex- there are three mammalian isoforms: A-Raf, B-Raf, and
pressed independently of whether or not carpels are C-Raf. Activation of the Raf proteins is mediated princi-
made (Heisler et al., 2001; Sessions et al., 1997). pally through binding of the small GTPase Ras in its GTP
Finally, as alluded to in the beginning, there is tremen- bound state. The importance of this signaling pathway in
dous interspecific variation in the degree of fruit de- cell growth control is underscored by the finding that
hiscence. As the Yanofsky and Sundaresan laboratories approximately 30% of all human cancers have activating
have shown, it is quite easy to make Arabidopsis fruits ras mutations (Bos, 1989). Furthermore, somatic muta-
indehiscent, both by knocking out or overexpressing tions in B-raf are found in a majority of human malignant
various fruit regulators. They have not yet shown, how- melanomas (Davies et al., 2002). As might be expected
ever, how the system can be tuned to supercharge the for a protein kinase that sits atop an important growth
dehiscence process and create explosive seedpods. control pathway, Raf proteins are subject to a complex
Since Arabidopsis has close relatives such as hairy bit- regulatory scheme, including autoinhibition of the kinase
ter-cress, Cardamine hirsuta, which can fling seeds a domain by the N-terminal region, Ras binding and trans-
couple of feet, one is hopeful that this will not be too location to the plasma membrane, stimulatory and inhib-
tough a nut to crack. itory serine/threonine and tyrosine phosphorylation, and
possibly interaction with 14-3-3 proteins (Kolch, 2000).
Over 30 missense mutations in the B-raf gene have
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Figure 1. Oncogenic Mutations in the B-Raf
Kinase Domain
The kinase domain of B-Raf is shown in back-
bone representation and colored gray, except
for the nucleotide binding loop (yellow), acti-
vation segment (blue), and the catalytic loop
(magenta). A portion of the activation segment,
represented by blue spheres, is disordered
in the crystal structure. The N- and C termini
are denoted by N and C. The small-molecule
inhibitor (BAY43-9006) cocrystallized with the
B-Raf kinase domain is shown in full-sphere
representation and colored black. Oncogenic
mutations have been mapped onto the back-
bone representation as stars, color coded ac-
cording to class. Mutations that strongly acti-
vate B-Raf kinase activity are colored green,
those that result in intermediate activation are
colored orange, and those that result in im-
paired B-Raf catalytic activity are colored red.
In the nucleotide binding loop (yellow), muta-
tions exist that, depending on the exact
amino acid change, fall into more than one
activation class. Such mutations are repre-
sented by bicolored stars. The positions of
two sites of oncogenic mutation, Gly-465 (P
loop), and Val-599 (activation segment), are
indicated, as well as the position of Asp-593
of the DFG motif in the activation segment.
with the kinase-impaired B-Raf mutants was dependent mutant) protein was unphosphorylated in the activation
segment, and thus the crystal structure should representon endogenous C-Raf activity. The high- and intermedi-
ate-activity B-Raf mutants also stimulated C-Raf activ- the inactive state of the B-Raf kinase.
A striking feature of the oncogenic mutations in theity, but C-Raf activity was not required for these B-Raf
mutants to stimulate ERK phosphorylation in cells. B-Raf kinase domain is their clustering to the nucleotide
binding loop (P loop) and to the N-terminal portion ofTo gain insights into the molecular basis for oncoge-
nicity of selected B-Raf mutants, Wan et al. (2004) deter- the activation segment (see Figure 1). The physical inter-
action between the P loop and the activation segment,mined crystal structures of the kinase domain of wild-
type B-Raf and of a high-activity mutant, Val-599→Glu, as observed in the crystal structure, is the key to under-
standing the mechanism of oncogenesis for the high-which is the predominant B-Raf mutant in human malig-
nant melanomas (Davies et al., 2002). To obtain crystals and intermediate-activity B-Raf mutants. In particular,
Val-599 in the activation segment (four residues beyondof suitable quality, it was necessary to cocrystallize the
B-Raf kinase domains, wild-type and mutant, with a the DFG motif) makes hydrophobic contacts with Phe-
467 in the P loop in the wild-type B-Raf kinase structure.small-molecule inhibitor of Raf, BAY43-9006. The crystal
structure of the B-Raf kinase domain displays the proto- With Val-599 stabilized in this position, the residues of
the DFG motif are not properly aligned for phosphoryltypical architecture of protein serine/threonine and tyro-
sine kinases, comprising an N-terminal and C-terminal transfer. Therefore, mutations that disrupt this kinase-
inactive state and/or stabilize the active state will resultlobe, between which lies the ATP binding cleft, which
is occupied by the inhibitor in these crystal structures. in elevated kinase activity. Both effects are likely
achieved through mutation of Val-599 to glutamic acid.Like the majority of protein kinases, Raf kinases (wild-
type) require phosphorylation (serine/threonine) in the If Val-599 is important in stabilizing the inactive state
of the B-Raf kinase, then one would expect that in theactivation segment for functional catalytic activity
(Chong et al., 2001). Phosphorylation of the 15–20 resi- crystal structure of the Val-599→Glu mutant, the activa-
tion segment would adopt a different conformation, onedue activation segment in protein kinases stabilizes a
configuration of this segment that is optimal for catalysis more similar to the phosphorylated, active conforma-
tion. Curiously, though, the activation segment confor-(Johnson et al., 1996). The activation segment begins
with the protein kinase-conserved DFG sequence motif. mation in the mutant structure is nearly identical to that
in the wild-type structure. Here, the cocrystallized inhibi-The aspartic acid of this motif coordinates an active site
Mg2 ion during phosphoryl transfer. The wild-type (and tor is probably the culprit for this obfuscation. BAY43-
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Wan, P.T.C., Garnett, M.J., Roe, S.M., Lee, S., Niculescu-Duvaz, D.,9906, like the c-Abl inhibitor STI-571/Gleevec (Schindler
Good, V.M., Cancer Genome Project, Jones, C.M., Marshall, C.J.,et al., 2000), has higher affinity for (and thus stabilizes)
Springer, C.J., et al. (2004). Cell 116, this issue, 855–867.the unphosphorylated, inactive conformation of the acti-
vation segment. Thus, in the Val-599→Glu B-Raf crystal
structure, the inhibitor dictates the conformation of the
activation segment more so than glutamic acid at
residue 599. Obedient and Wayward
For the impaired-activity class of B-Raf mutants, loss Synaptic Behaviorof kinase activity is relatively easy to rationalize. For
example, two mutations in this class lead to substitu-
tions of a protein kinase-invariant glycine in the P loop
(Gly-465) with valine or glutamic acid. Any amino acid
Synapse formation is a complex process that culmi-other than glycine at this position would adversely affect
nates in the linking up and locking in of pre- and post-ATP binding. What is less easy to rationalize is how this
synaptic membranes. Shen et al. (2004 [this issue ofclass of mutants results in trans-activation of C-Raf.
Cell]) begin to dissect the molecular instructions thatWan et al. (2004) propose that the unifying feature for
govern target selection of pre- and postsynaptic mem-all three classes of oncogenic mutants is the resultant
brane interactions.destabilization of the inactive conformation of the acti-
vation segment. For the impaired-activity mutants, one
conceivable hypothesis is that the conformational change Synaptogenesis is the process by which nascent pre-
in the B-Raf activation segment, induced through muta- and postsynaptic membranes link up and lock in to form
tion, is transmitted to a C-Raf molecule in the same an adhesive junction across which information in the
complex, resulting in its activation. Although the detailed form of chemical or electrical signals is transferred. It
mechanisms are surely different, the ability of B-Raf to is the end product of an extraordinary process that has
elicit a biological response through a conformational been conveniently partitioned into sequentially ob-
change rather than by phosphorylation is reminiscent served phenomena—axon guidance, gross target rec-
of IRE1, a protein kinase involved in the unfolded protein ognition, fine target recognition, and ultimately, synapse
response (Papa et al., 2003). formation (Holt and Harris, 1998). These stages of syn-
The study by Wan et al. (2004) provides biochemical apse development correlate with observations in situ in
insights into the mechanisms by which B-Raf, a protein well-studied invertebrate and vertebrate systems. How-
kinase important in cell growth control, can be deregu- ever, the underlying controlling elements—the molecu-
lated through mutation. From a human disease stand- lar basis for synaptic specificity and synaptic junction
point, the results of this study are sobering for two rea- formation—are largely unknown. The development con-
sons. First, despite multiple regulatory mechanisms tinuum that begins with neurite outgrowth and culmi-
governing the activation state of B-Raf, a single point nates with the formation of a specific synapse is the
mutation is sufficient to trump these safeguards and result of a continual interplay between the unfolding
lead to transformation. Second, and more insidious, mu- neural genetic program and local environmental influ-
tations in this same protein kinase that cripple the en- ences on the outgrowing neurite (Benson et al., 2001).
zyme can nevertheless result in a gain-of-function Although we are still in the dark in terms of very basic
growth phenotype—losses yielding gains. questions about synaptogenesis, some recent experi-
ments have uncovered certain instructive subtleties that
are quite revealing about the nature of the controllingStevan R. Hubbard
molecules that operate near the end of the line, that is,
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an interesting case in point is in the visual system of
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Drosophila, where the selective ablation of N-cadherin
from photoreceptor neurons engenders visual defects
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